Dr. Gary Raskob is Dean of the College of Public Health, and a Professor of Epidemiology and Medicine, at the University of Oklahoma Health Science Center in Oklahoma City, OK. He specializes in research and treatment of blood clotting disorders and the development of antithrombotic drugs (drugs that reduce the formation of blood clots). He also serves as chair of the Medical and Scientific Advisory Board of the National Blood Clot Alliance, an organization dedicated to advancing the prevention, early diagnosis and successful treatment of life-threatening blood clots.
In this webinar Dean Raskob will review the disease burden from venous thromboembolism (VTE), and discuss strategies to reduce this burden through prevention of both first time and recurrent clots. He will also describe the clinical features of the two components that together comprise VTE: deep vein thrombosis (DVT), a condition in which a blood clot forms in a deep vein of the body, usually the leg, and pulmonary embolism (PE), the condition that occurs when a blood clot breaks away and travels to the lungs and can be fatal. Dean Raskob will review what is known about the risk factors for VTE and discuss steps that people can take to reduce their risks.
More information: http://www.cdc.gov/ncbddd/dvt/documents/vte_save_the_date_nov2014.pdf